Vr-Adviser

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "TRVI",
  "ORIC",
  "TIL",
  "ABVX",
  "ATXS",
  "SVRA",
  "PHVS",
  "ARTV",
  "APLT",
  null,
  "SYRE",
  "APGE",
  "KALV",
  "MRSN",
  null,
  "TNYA",
  "SRZN",
  "ZURA",
  null,
  "UPB",
  "SLDB",
  "PRAX",
  "FDMT",
  "TENX",
  "COGT",
  "DYN",
  "GLYC",
  null,
  "CDTX",
  "ERAS",
  "ELVN",
  "VRDN",
  "ORKA",
  "IPSC",
  "CGEM",
  "DNTH"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 37
Total Value: 1175247364
Accession Number: 0001415889-25-013093
Form Type: 13F-HR
CIK: vr-adviser
Manager Name: Vr-Adviser

Data Enrichment

89% identified

33 identified4 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

37 positions • $1.2B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

Solid Biosciences Inc.

SLDB|83422E204

Shares:2.5M

Value:$9.2M

% of Portfolio:0.8% ($9.2M/$1.2B)

Savara Inc

SVRA|805111101

Shares:3.3M

Value:$9.0M

% of Portfolio:0.8% ($9.0M/$1.2B)

Abivax S.A.

ABVX|00370M103

Shares:1.3M

Value:$8.4M

% of Portfolio:0.7% ($8.4M/$1.2B)

G70077105

Shares:750.0K

Value:$7.7M

% of Portfolio:0.7% ($7.7M/$1.2B)

Surrozen, Inc./DE

SRZN|86889P208

Shares:632.9K

Value:$7.4M

% of Portfolio:0.6% ($7.4M/$1.2B)

Zura Bio Ltd

ZURA|G9TY5A101

Shares:5.0M

Value:$6.5M

% of Portfolio:0.6% ($6.5M/$1.2B)

Artiva Biotherapeutics, Inc.

ARTV|04317A107

Shares:1.6M

Value:$4.8M

% of Portfolio:0.4% ($4.8M/$1.2B)

Trevi Therapeutics, Inc.

TRVI|89532M101

Shares:615.5K

Value:$3.9M

% of Portfolio:0.3% ($3.9M/$1.2B)

Applied Therapeutics, Inc.

APLT|03828A101

Shares:5.6M

Value:$2.7M

% of Portfolio:0.2% ($2.7M/$1.2B)

4D Molecular Therapeutics, Inc.

FDMT|35104E100

Shares:677.6K

Value:$2.2M

% of Portfolio:0.2% ($2.2M/$1.2B)

G1933S101

Shares:987.3K

Value:$2.1M

% of Portfolio:0.2% ($2.1M/$1.2B)

TENAX THERAPEUTICS, INC.

TENX|88032L605

Shares:208.3K

Value:$1.4M

% of Portfolio:0.1% ($1.4M/$1.2B)

Mersana Therapeutics, Inc.

MRSN|59045L106

Shares:3.6M

Value:$1.2M

% of Portfolio:0.1% ($1.2M/$1.2B)

Century Therapeutics, Inc.

IPSC|15673T100

Shares:2.5M

Value:$1.2M

% of Portfolio:0.1% ($1.2M/$1.2B)

Tenaya Therapeutics, Inc.

TNYA|87990A106

Shares:1.6M

Value:$886.8K

% of Portfolio:0.1% ($886.8K/$1.2B)

GLYCOMIMETICS INC

GLYC|38000Q102

Shares:3.0M

Value:$630.0K

% of Portfolio:0.1% ($630.0K/$1.2B)

Instil Bio, Inc.

TIL|45783C200

Shares:33.2K

Value:$576.0K

% of Portfolio:0.0% ($576.0K/$1.2B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Solid Biosciences Inc.(SLDBcusip83422E204)	2.5M	QoQ NEW(+2.5M) YoY NEW(+2.5M)	All Managers (Combined)	$9.2M	0.8% ($9.2M/$1.2B)	QoQ NEW(+$9.2M) YoY NEW(+$9.2M)
Savara Inc(SVRAcusip805111101)	3.3M	QoQ NEW(+3.3M) YoY NEW(+3.3M)	All Managers (Combined)	$9.0M	0.8% ($9.0M/$1.2B)	QoQ NEW(+$9.0M) YoY NEW(+$9.0M)
Abivax S.A.(ABVXcusip00370M103)	1.3M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$8.4M	0.7% ($8.4M/$1.2B)	QoQ -14.61% (-$1.4M) YoY -56.29% (-$10.8M)
(cusipG70077105)✕	750.0K	QoQ 0.00% (+0) YoY NEW(+750.0K)	All Managers (Combined)	$7.7M	0.7% ($7.7M/$1.2B)	QoQ +1.17% (+$90.0K) YoY NEW(+$7.7M)
Surrozen, Inc./DE(SRZNcusip86889P208)	632.9K	QoQ NEW(+632.9K) YoY NEW(+632.9K)	All Managers (Combined)	$7.4M	0.6% ($7.4M/$1.2B)	QoQ NEW(+$7.4M) YoY NEW(+$7.4M)
Zura Bio Ltd(ZURAcusipG9TY5A101)	5.0M	QoQ +148.28% (+3.0M) YoY NEW(+5.0M)	All Managers (Combined)	$6.5M	0.6% ($6.5M/$1.2B)	QoQ +28.11% (+$1.4M) YoY NEW(+$6.5M)
Artiva Biotherapeutics, Inc.(ARTVcusip04317A107)	1.6M	QoQ 0.00% (-0) YoY NEW(+1.6M)	All Managers (Combined)	$4.8M	0.4% ($4.8M/$1.2B)	QoQ -70.23% (-$11.4M) YoY NEW(+$4.8M)
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	615.5K	QoQ -51.39% (-651.0K) YoY -82.01% (-2.8M)	All Managers (Combined)	$3.9M	0.3% ($3.9M/$1.2B)	QoQ -25.80% (-$1.3M) YoY -67.21% (-$7.9M)
Applied Therapeutics, Inc.(APLTcusip03828A101)	5.6M	QoQ -44.27% (-4.4M) YoY -38.64% (-3.5M)	All Managers (Combined)	$2.7M	0.2% ($2.7M/$1.2B)	QoQ -68.17% (-$5.8M) YoY -95.58% (-$59.0M)
4D Molecular Therapeutics, Inc.(FDMTcusip35104E100)	677.6K	QoQ -77.04% (-2.3M) YoY -84.60% (-3.7M)	All Managers (Combined)	$2.2M	0.2% ($2.2M/$1.2B)	QoQ -86.69% (-$14.3M) YoY -98.43% (-$138.0M)
(cusipG1933S101)✕	987.3K	QoQ 0.00% (-0) YoY NEW(+987.3K)	All Managers (Combined)	$2.1M	0.2% ($2.1M/$1.2B)	QoQ -23.67% (-$661.5K) YoY NEW(+$2.1M)
TENAX THERAPEUTICS, INC.(TENXcusip88032L605)	208.3K	QoQ 0.00% (+0) YoY NEW(+208.3K)	All Managers (Combined)	$1.4M	0.1% ($1.4M/$1.2B)	QoQ +5.81% (+$75.0K) YoY NEW(+$1.4M)
Mersana Therapeutics, Inc.(MRSNcusip59045L106)	3.6M	QoQ -65.15% (-6.7M) YoY -68.44% (-7.8M)	All Managers (Combined)	$1.2M	0.1% ($1.2M/$1.2B)	QoQ -91.61% (-$13.4M) YoY -97.57% (-$49.5M)
Century Therapeutics, Inc.(IPSCcusip15673T100)	2.5M	QoQ -36.87% (-1.5M) YoY -26.63% (-907.1K)	All Managers (Combined)	$1.2M	0.1% ($1.2M/$1.2B)	QoQ -70.24% (-$2.8M) YoY -91.64% (-$13.0M)
Tenaya Therapeutics, Inc.(TNYAcusip87990A106)	1.6M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$886.8K	0.1% ($886.8K/$1.2B)	QoQ -60.13% (-$1.3M) YoY -89.09% (-$7.2M)
GLYCOMIMETICS INC(GLYCcusip38000Q102)	3.0M	QoQ 0.00% (-0) YoY NEW(+3.0M)	All Managers (Combined)	$630.0K	0.1% ($630.0K/$1.2B)	QoQ -15.66% (-$117.0K) YoY NEW(+$630.0K)
Instil Bio, Inc.(TILcusip45783C200)	33.2K	QoQ 0.00% (-0) YoY NEW(+33.2K)	All Managers (Combined)	$576.0K	0.0% ($576.0K/$1.2B)	QoQ -9.06% (-$57.4K) YoY NEW(+$576.0K)